Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
In a lively debate, James Johnston MD, JD, and James Burke, MD, discussed whether neuroimaging is appropriate for patients with headache. Read more about their session at AAN’s 2019 Annual Meeting and post...
In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...
Findings from a new study have clarified the potential associations of migraine with various adverse cardiovascular events including myocardial infarction, ischemic stroke, and venous thromboembolism.
Migraine surgery candidates have chronic pain with significant disability. In a recent study, researchers evaluated the effect of migraine surgery on pain, coping ability, and functional status in patients...
In a recent study, researchers tested the efficacy of a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor for preventing episodic migraines and improving...
Intravenous hydromorphone is commonly used for the treatment of migraines in the emergency department, but whether a non-opioid option, IV prochlorperazine plus diphenhydramine, could be more effective has...
